NCT04151472View on ClinicalTrials.gov

Idebenone for the Preventive Treatment of Migraine

PHASE3RecruitingINTERVENTIONAL
Enrollment

180

Participants

Timeline

Start Date

December 8, 2021

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Migraine DisordersHeadache Disorders
Interventions
DRUG

Placebo

Placebo oral tablet, three times a day

DRUG

90mg Idebenone

Idebenone 30 MG Oral Tablet, three times a day

DRUG

270mg Idebenone

Idebenone 90 MG Oral Tablet, three times a day

Trial Locations (1)

370001

RECRUITING

Kaiming Liu, Hangzhou

All Listed Sponsors
lead

Second Affiliated Hospital, School of Medicine, Zhejiang University

OTHER